Fundraising Fox

Alessa Therapeutics

San Carlos, US · Founded 2018 · Delaware corporation · 3 known investors

alessatherapeutics.com ↗

Alessa Therapeutics develops a proprietary drug-delivery platform for sustained and localized release of therapies to treat early-stage prostate cancer. The company is advancing Enolen, a drug-eluting implant designed to deliver enzalutamide directly to the prostate with fewer systemic side effects than existing treatments.

BiotechHealthtechMedical Devicesin /alessa-therapeutics-inc

Founders & leadership

PM
Pamela MunsterFounder, Chief Scientific Advisor and Director
ZC
Zachary CollinsExecutive Officer
CG
Cam GallagherinExecutive Officer, Director
RLRichard Lim
Richard LiminDirector
JM
John MaroneyExecutive Officer, Director
DCDoug Crawford
Doug CrawfordinDirector
STSteve Tregay
Steve TregayinDirector
AMAnnie Mitsak
Annie MitsakinDirector
PP
Peter ParkerDirector

Investors · 3

Cure VenturesBoston
Mission Bay CapitalSan Francisco
Mission BiocapitalSan Francisco · $500K

Reported raises · per SEC filings

Form D private placements
▶$25.4MraisedMay 2025 · 14 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Zachary CollinsExecutive Officer
  • Cam GallagherExecutive Officer, Director
  • Steve TregayDirector
  • Douglas CrawfordDirector
  • Annie MitsakDirector
  • Richard LimDirector
  • Pamela MunsterDirector
Offering amount
$31.6M
Amount sold
$25.4M
Minimum investment
$1
First sale
Apr 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.3MraisedJan 2020 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter ParkerDirector
  • Pamela MunsterDirector
  • John MaroneyExecutive Officer, Director
  • Doug CrawfordDirector
Offering amount
$3.5M
Amount sold
$3.3M
Minimum investment
$1
First sale
Dec 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedMar 2019 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John MaroneyExecutive Officer, Director
  • Doug CrawfordDirector
  • Pamela MunsterDirector
  • Peter ParkerDirector
Offering amount
$3.5M
Amount sold
$3M
Minimum investment
$1
First sale
Mar 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news